Patents by Inventor Leif Oxburgh

Leif Oxburgh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treating inflammation and fibrosis
    Patent number: 9890208
    Abstract: The present invention features compositions featuring agents that bind to denatured collagen and methods of using such agents to treat or prevent fibrosis or inflammation in a subject.
    Type: Grant
    Filed: September 17, 2014
    Date of Patent: February 13, 2018
    Assignee: Maine Medical Center
    Inventors: Peter C. Brooks, Leif Oxburgh, Jennifer M. Caron
  • Culture conditions for expansion of nephron progenitor cells
    Patent number: 9752115
    Abstract: The present invention relates to compositions and methods associated with cocktails of growth factors and small molecules that target specific cell signaling pathways, the cocktails having been formulated to allow/promote the expansion of progenitor cells (e.g., nephron progenitor cells) within a defined culture system.
    Type: Grant
    Filed: February 26, 2015
    Date of Patent: September 5, 2017
    Assignee: Maine Medical Center Research Institute
    Inventors: Leif Oxburgh, Aaron Brown
  • CULTURE CONDITIONS FOR EXPANSION OF NEPHRON PROGENITOR CELLS
    Publication number: 20150275168
    Abstract: The present invention relates to compositions and methods associated with cocktails of growth factors and small molecules that target specific cell signaling pathways, the cocktails having been formulated to allow/promote the expansion of progenitor cells (e.g., nephron progenitor cells) within a defined culture system.
    Type: Application
    Filed: February 26, 2015
    Publication date: October 1, 2015
    Inventors: Leif Oxburgh, Aaron Brown
  • COMPOSITIONS AND METHODS FOR TREATING INFLAMMATION AND FIBROSIS
    Publication number: 20150010552
    Abstract: The present invention features compositions featuring agents that bind to denatured collagen and methods of using such agents to treat or prevent fibrosis or inflammation in a subject.
    Type: Application
    Filed: September 17, 2014
    Publication date: January 8, 2015
    Inventors: Peter C. Brooks, Leif Oxburgh, Jennifer M. Caron